A deep eutectic-based, self-emulsifying subcutaneous depot system for apomorphine therapy in Parkinson’s disease
Open Access
- 23 February 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (9)
Abstract
Significance: Parkinson’s disease (PD) is a progressive disorder of the central nervous system that affects motor control. While subcutaneous injection of apomorphine (Apokyn) is clinically used to alleviate intermittent episodes of dyskinesia, the treatment requires multiple injections of the drug per day, significantly deterring patient compliance. We introduce a deep eutectic-based ternary solvent system that self-emulsifies in situ following subcutaneous injection and entraps apomorphine, allowing a 48-h duration of detectable drug concentration in the plasma of pigs, which is a remarkable improvement over the clinical comparator. The results from the animal studies support the self-emulsifying system as a potent, long-lasting therapeutic for PD patients and potentially for other therapeutics that have a similar delivery challenge.Keywords
Funding Information
- Promius Pharma (None)
This publication has 34 references indexed in Scilit:
- Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimagingInternational Journal of Nanomedicine, 2012
- Oral Apomorphine Delivery from Solid Lipid Nanoparticles with Different Monostearate Emulsifiers: Pharmacokinetic and Behavioral EvaluationsJournal of Pharmaceutical Sciences, 2011
- Quantitative Risk Analysis for N-Methyl Pyrrolidone Using Physiologically Based Pharmacokinetic and Benchmark Dose ModelingToxicological Sciences, 2009
- Parkinson's disease: clinical features and diagnosisJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's diseaseNeurological Sciences, 2002
- Pharmacokinetics of apomorphine in parkinsonian patientsFundamental & Clinical Pharmacology, 1993
- Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routes.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Absorption of apomorphine by various routes in parkinsonismMovement Disorders, 1991
- Peripheral pharmacokinetics of apomorphine in humansAnnals of Neurology, 1989
- The on-off phenomenon.Journal of Neurology, Neurosurgery & Psychiatry, 1989